Some problems and errors in cytogenetic biodosimetry by Mosse, Irma et al.
                                                                    
University of Dundee
Some problems and errors in cytogenetic biodosimetry
Mosse, Irma; Kilchevsky, Alexander; Nikolova, Nevena; Zhelev, Nikolai
Published in:
Biotechnology and Biotechnological Equipment
DOI:
10.1080/13102818.2016.1259018
Publication date:
2017
Document Version
Publisher's PDF, also known as Version of record
Link to publication in Discovery Research Portal
Citation for published version (APA):
Mosse, I., Kilchevsky, A., Nikolova, N., & Zhelev, N. (2017). Some problems and errors in cytogenetic
biodosimetry. Biotechnology and Biotechnological Equipment, 31(3), 460-468.
https://doi.org/10.1080/13102818.2016.1259018
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 07. Dec. 2019
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=tbeq20
Biotechnology & Biotechnological Equipment
ISSN: 1310-2818 (Print) 1314-3530 (Online) Journal homepage: https://www.tandfonline.com/loi/tbeq20
Some problems and errors in cytogenetic
biodosimetry
Irma Mosse, Alexander Kilchevsky, Nevena Nikolova & Nikolai Zhelev
To cite this article: Irma Mosse, Alexander Kilchevsky, Nevena Nikolova & Nikolai Zhelev
(2017) Some problems and errors in cytogenetic biodosimetry, Biotechnology & Biotechnological
Equipment, 31:3, 460-468, DOI: 10.1080/13102818.2016.1259018
To link to this article:  https://doi.org/10.1080/13102818.2016.1259018
© 2016 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group
Published online: 14 Dec 2016.
Submit your article to this journal 
Article views: 476
View related articles 
View Crossmark data
REVIEW; MEDICAL BIOTECHNOLOGY
Some problems and errors in cytogenetic biodosimetry
Irma Mossea, Alexander Kilchevskya, Nevena Nikolovab and Nikolai Zhelev c
aNational Academy of Sciences, Institute of Genetics and Cytology, Minsk, Belarus; bFaculty of Veterinary Medicine, Trakia University, Stara
Zagora, Bulgaria; cCentre for Molecular Cellular Biosensor Research (CMCBR), School of Science, Engineering and Technology, Abertay
University, Dundee, Scotland, UK
ARTICLE HISTORY
Received 1 October 2016
Accepted 7 November 2016
ABSTRACT
Human radiosensitivity is a quantitative trait that is generally subject to binomial distribution.
Individual radiosensitivity, however, may deviate signiﬁcantly from the mean (by 2–3 standard
deviations). Thus, the same dose of radiation may result in different levels of genotoxic damage
(commonly measured as chromosome aberration rates) in different individuals. There is signiﬁcant
genetic component in individual radiosensitivity. It is related to carriership of variant alleles of
various single-nucleotide polymorphisms (most of these in genes coding for proteins functioning
in DNA damage identiﬁcation and repair); carriership of a different number of alleles producing
cumulative effects; ampliﬁcation of gene copies coding for proteins responsible for radioresistance,
mobile genetic elements and others. Among the other factors inﬂuencing individual
radioresistance are: the radioadaptive response; the bystander effect; the levels of endogenous
substances with radioprotective and antimutagenic properties and environmental factors such as
lifestyle and diet, physical activity, psychoemotional state, hormonal state, certain drugs, infections
and others. These factors may have radioprotective or sensibilizing effects. Apparently, there are
too many factors that may signiﬁcantly modulate the biological effects of ionizing radiation. Thus,
conventional methodologies for biodosimetry (speciﬁcally, cytogenetic methods) may produce
signiﬁcant errors if personal traits that may affect radioresistance are not accounted for.
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Abbreviations
ERCC1 – excision repair, complementing defective
HPV – human papilloma virus
IR – ionizing radiation
MLH – homologue of MutL of E. coli
RRM1 – ribonucleotide reductase
SCID – severe combined immunodeﬁciency
SD – standard deviation from the mean
SOD – superoxide dismutase
XPC – Xeroderma pigmentosum complementation
group C
XPD – Xeroderma pigmentosum complementation
group D
XPG – Xeroderma pigmentosum complementation
group G
XRCC – X-ray repair complementing defective
UTR – untranslated region
Introduction
The correlation between the received dose of ionizing
radiation (IR) and its biological effects (increases in the
levels of intracellular free radical species, increased level
of genomic instability, increased mutation rate, induc-
tion of apoptosis, increased risk for neoplastic transfor-
mation) is not always straightforward. Several cases of
naturally occurring extreme radioresistance in humans
have been reported, usually in case reports of survivors
of industrial accidents [1,2]. Thus, simple calculation of
the received dose may not be sufﬁcient when assessing
the effects of exposure to IR. Biological dosimetry is
based on assessment of genotoxic damage using spe-
ciﬁc biomarkers and may provide a more reliable source
of information about the effects of IR. The ﬁrst validated
methodology for biological dosimetry (the dicentric
assay, based on analysis of solid stained dicentric chro-
mosomes in lymphocytes from peripheral blood) was
introduced in the mid-1960s. For decades, the dicentric
assay was the only method of biological dosimetry avail-
able, and in our day, it is still the technique that is most
frequently used. There may be, nevertheless, a discrep-
ancy between the assessment of the effects of irradiation
obtained in vitro (using whole blood or cultured lympho-
cytes) and in vivo. Basically, the dicentric assay produces
results that correlate well with the irradiation dose when
carried out in cultured cells, but may not be reliable
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when assessing the effects of IR in vivo, as there are
many factors that affect individual radiosensitivity,
endogenous as well as exogenous, in living organisms.
The major factors determining individual radiosensitivity
that may be source of biodosimetric errors are reviewed
below.
Binomial distribution of radiosensitivity vs.
individual radiosensitivity
Radiosensitivity is a quantitative trait. Its distribution
within the population is characterized by a ‘bell-like
curve’. Thus, approximately 50% of the population exhib-
its an ‘average’ radiosensitivity (x § 0.67 standard devia-
tions (SDs)). The majority (95%) of individuals within the
population exhibit radiosensitivity of x § 1.96 SDs. Only
approximately 5% of the population falls within the
range of x § 1.96 SDs to x § 3 SDs. The latter group may
be sub-divided further into the extremely radiosensitive
(2.5%) and the extremely radioresistant fraction (the
remaining 2.5%).
The proportion of people that exhibit sensitivity to
irradiation increases with increase of the received dose,
although the correlation is not directly proportional.
There is a steep increase in the proportion of radiosensi-
tive individuals with increase of the dose, corresponding
to the ‘extremely sensitive’ individuals and the ‘average-
sensitive’ individuals, followed by a steep decline in the
number of radiosensitive individuals, corresponding to
the ‘extremely radioresistant’ fraction of the population.
There has always been some contradiction about the
existence of a ‘threshold’ dose of IR that may result in
genotoxic effects (that is, whether a dose below the
‘threshold dose’ may not be associated with any geno-
toxic effects). The existence of an ‘extremely radiosensi-
tive’ fraction, however, may invalidate the theory of the
‘threshold dose’, as there is always a small proportion of
individuals in a population that may suffer lasting effects
from a dose that causes no harmful effects in the major-
ity of individuals. Indeed, if the study cohorts are too
small or the assays used to assess genotoxic effects
exhibit low sensitivity tests, ‘extreme radiosensitivity’
may not be registered, which would manifest as an
apparent dose ‘threshold’ followed by a steep increase
in radiosensitivity.
Apparently, individual radiosensitivity may differ sig-
niﬁcantly from the ‘average’ radiosensitivity within a
population, and, respectively, the same received dose
may result in dissimilar genotoxic effects.
There is signiﬁcant genetic component in individual
radiosensitivity. It is related to carriership of variant
alleles of various single-nucleotide polymorphisms (most
of these in genes coding for proteins functioning in DNA
damage identiﬁcation and repair), carriership of a differ-
ent number of alleles producing cumulative effects,
ampliﬁcation of gene copies coding for proteins respon-
sible for radioresistance, mobile genetic elements and
others. Among the other factors inﬂuencing individual
radioresistance are: the levels of endogenous substances
with radioprotective and antimutagenic properties; the
adaptive response and the bystander effect; and envi-
ronmental factors such as lifestyle and diet, physical
activity, psychoemotional state, hormonal status, certain
drugs (e.g. cytostatic medication), infections and others.
These factors may have radioprotective or sensibilizing
effects.
Individual capacity for DNA repair
The efﬁciency of repair of DNA damage inﬂicted by IR
may be quite dissimilar in different individuals. Exquisite
sensitivity to IR and radiomimetic drugs (bleomycin, neo-
carzinostatin and others) is part of the clinical picture in
inherited disorders of DNA damage-associated response
and/or repair such as ataxia-telangiectasia, Nijmegen
breakage syndrome and various severe combined
immunodeﬁciency (SCID)/radiosensitivity syndromes [3–
6]. Even among the clinically healthy individuals, how-
ever, the response to DNA damage may greatly vary. It is
currently believed that individual radioresistance is
determined by a variety of factors, including speciﬁcities
in the genetic background, speciﬁcities in the physiology
of the cells and tissues that received the irradiation, and
environmental factors [7,8].
Carriership of a common polymorphism in the XPC
gene coding for a major protein of DNA damage recog-
nition and repair has been associated with increased
sensitivity to bleomycin [9]. This and other polymor-
phisms in genes of DNA repair (XPD Lys751Gln, XPG
Asp1104His, XRCC1 Arg399Gln and XRCC3 Thr241 Met)
were associated with increased levels of strand breaks
and chromosomal aberrations in healthy human volun-
teers [10].
It is well known that tissues with rapid turnover such
as bone marrow and epithelia are signiﬁcantly more vul-
nerable to the effects of IR than tissues containing long-
lived cells that are rarely (if ever) replaced, such as neuro-
nal tissue. The latter is believed to be related to the prin-
ciple of parsimony of DNA repair mechanisms typical of
the DNA repair proﬁle in certain species (‘the rodent
repairadox’) and in certain types of cells (adult neurons,
memory B-cells) that ensures that only transcribed DNA
is repaired [11–13]. Indeed, cells that are not expected to
divide may not be subjected to the genome integrity
checks that are routinely carried out in dividing cells and
are, therefore, not likely to be assessed as too damaged
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to keep [14,15]. This mechanism seems to ensure neuro-
nal lifespan roughly comparable to the lifespan of the
organism, although some authors speculate that
increased attrition of adult neurons secondary to oxida-
tive damage and poor supply of replacement neurons
from the neuronal stem cell niche may constitute an
important component of the pathogenetic mechanism
of late-onset neurodegenerative disease [16–18]. In any
case, assessment of IR-inﬂicted damage may show very
different results when carried out in radiosensitive and
radioresistant types of cells and tissues.
Modern anticancer therapy (including radiotherapy) is
largely based on suppression of proliferation of cancer
cells by inﬂicting enough damage in their DNA so as to
activate the mechanisms that ensure that cells with com-
promised genome integrity are not replicating their
DNA. More aggressive therapies are therefore more likely
to produce the desired effect of staving off tumour
growth. Nevertheless, agents and/or treatments that
produce rapid and severe suppression of cell division are
inevitably associated with increased rates of adverse
effects (anaemia, agranulocytopenia, mucositis, epila-
tion, etc.). Carriership of polymorphisms in genes coding
for proteins of DNA damage-associated response and/or
DNA repair may be associated with differential response
to radiotherapy in terms of survival and/or rates of
adverse effects [19,20]. Low levels of mRNA of proteins
acting in replicative synthesis of DNA (ERCC1, RRM1) and
heterozygous carriership of the single-nucleotide poly-
morphism ERCC1 T19007C may be associated with
increased chances for tumour regression/increased sur-
vival in patients with certain types of solid tumours
treated with radiotherapy alone or as part of a combined
chemotherapy/radiotherapy regimen [21–24].
The locus containing the TP53 gene is altered
(mutated or altogether deleted) in about half of human
cancers [25]. Modiﬁcation of the TP53 gene in tumour
cells is usually associated with poorer prognosis for the
patient [25,26]. P53 is activated in response to acute
DNA damage caused by radiation [27] and at least in
some tumours, loss of the TP53 locus may be associated
with increased risk of radioresistance [28]. In HPV-related
human tumours such as cervical carcinoma and head
and neck cancers, the presence of viral DNA in the
tumour tissue may be associated with better prognosis
for the patients (reviewed in [29]). Recently, the presence
of human papilloma virus DNA in tumour samples has
been reported to be associated with increased radiosen-
sitivity as well [30].
Carriership of the XRCC1 Arg399Gln, XRCC3
Thr241Met and SOD2 codon 16 polymorphisms may be
associated with increased risk of subcutaneous ﬁbrosis
after radiotherapy [31,32]. The presence of XRCC1
399Gln and APE1 148Glu polymorphisms in breast can-
cer patients was associated with reduced risk for moist
desquamation of irradiated normal skin in patients with
breast cancer treated with radiotherapy [33]. The very
common TP53 Pro72Arg polymorphism was found to be
associated with development of atypical vascular lesions
at the sites of radiotherapy for breast carcinoma [34].
The polymorphisms LIG4 Asp568Asp, XPD Asp711Asp,
the 5'-UTR A > G polymorphism at nt4541 in the XRCC3
gene and MLH1 Val219Ile are associated with late rectal
and/or bladder toxicity in patients treated with radio-
therapy for prostate cancer [35]. ATM protein is one of
the key radiation sensors in the cell [36,37] and several
polymorphisms in the ATM gene were found to be asso-
ciated with increased risk for severe radiation pneumoni-
tis, a common complication in patients with lung cancer
treated with radiotherapy [38].
The risk of anticancer therapy-related toxicity con-
ferred by virtually all of the genetic factors listed above
may be modulated by other factors, including environ-
mental factors (smoking, obesity, etc.). Obesity is a major
risk factor for acute toxicity in virtually all types of anti-
cancer treatments [39–41]. This adverse effect is most
likely related to the higher dose of the genotoxic agent
that is required to achieve the desired effect in larger
patients. History of smoking and continuing to smoke
after receiving the diagnosis of cancer may result in up-
regulation of the mechanisms of DNA repair, resulting in
more efﬁcient elimination of the DNA damaging agents
of genotoxic therapy. Studies show that the response to
radiotherapy was poorer in smoking patients with head
and neck cancers than in non-smokers [42].
Apparently, the genetic background plays a major
role in the constitution of individual radiosensitivity, or,
as the famous radiobiologists Mothersill and Seymour
propose: ‘Clearly, genetic predisposition is crucial and
may even be more important than dose’ [43]. This, nev-
ertheless, is valid only within certain limits, as it is pres-
ently believed that there are natural mechanisms that
prevent both ‘ultimate resistance to mutation’ and ‘ulti-
mate propensity for mutation’ in order to keep the evo-
lution going [44,45].
Analysis of DNA polymorphisms in genes coding for
products responsible for identiﬁcation and repair of DNA
damage inﬂicted by IR may be complemented by meth-
odology that assesses the outward expression of the
overall capacity for repair of damage (phenotypic analy-
sis). There are several methods that may be used to
monitor the overall capacity for repair of induced dam-
age of a speciﬁc type and/or the genomic stability in
selected sequences [46–48]. The methodologies
described in [46] and [48] have been developed to assess
levels of ultraviolet (UV)-induced damage, but it may be
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expected that they could be easily adapted for assess-
ment of damage inﬂicted by IR.
Radioadaptive response
The phenomenon of radioadaptive response is another
major factor that may be responsible for the discrepan-
cies between the anticipated effects of the received
dose and the biological effects in vivo. By deﬁnition, the
adaptive response is a speciﬁc reaction that occurs on
the level of whole cells, tissues or organisms in response
to stress. The adaptive response is dose-dependent, with
the adapting (priming) dose being signiﬁcantly smaller
(sometimes by several orders of magnitude) than the
dose that causes acute damage. Typically, the priming
dose does not cause any detectable damage. However,
when a larger dose (usually associated with acute dam-
age) is received following a priming dose, a signiﬁcant
reduction in the rate of occurrence of the associated
harmful effects may be noted. Usually, administration of
a priming irradiation dose reduces the effects of an acute
radiation dose by a factor of 2 [49]. Apparently, the radio-
adaptive response can modify biodosimetry results.
Radioadaptive response may be elicited not only by a
smaller priming dose of irradiation, but also by agents
other than IR, such as thermal shock, chemical mutagens
and others, the majority of which could not be con-
trolled under normal conditions (stress, vitamin and anti-
oxidant intake, etc.). What is more, the protective effect
of a priming dose may be observed not only when the
priming and the damaging agent are of the same nature
(e.g. a smaller dose of radiation followed by a larger
dose), but also when the priming and the damaging fac-
tor are different (e.g. a small dose of UV irradiation may
protect from the harmful effects of a dose of IR that is
usually associated with acute damage). The protective
effects of the radioadaptive response may be observed
on many levels, using biomarkers for genotoxic damage
such as rates of occurrence of chromosomal aberrations,
mutation rates, the micronucleus assay, etc. For damage
caused by IR, it has been observed that the time interval
between the priming dose and the damaging dose that
is associated with the strongest radioadaptive response
is 5–6 hours [49]. Reducing the time interval between
exposures results in decrease of the radioadaptive
response. Increasing the time interval between subse-
quent doses up to 10 hours does not result in decrease
of the radioadaptive response [49].
The adaptive response may be observed with some
damaging agents but not with others. In the late 1970s
and early 1980s, signiﬁcant variation was observed in
the repair responses of cultured human lymphocytes
from healthy volunteers to DNA damage induced by
chemical agents [50,51]. This, however, may not pertain
to all types of genotoxic damage, as there are reports in
the specialized literature that there was virtually no mea-
surable radioadaptive response in lymphocytes from
unrelated healthy volunteers [49,52]. In any case, the
results of assessments of genotoxic damage may be
quite different in cases when a priming dose has been
administered and in cells, tissues and organisms that are
naive to IR.
The radioadaptive response may be modulated by
different agents. It was previously shown that the pig-
ment melanin reduced the mutation rates by a factor of
2 and contributed to the adaptive response, resulting in
reduction of the rate of chromosomal aberrations by a
factor of 4 [53,54]. In a previous study, we revealed that
certain mutagens such as the herbicide Senkor pre-
vented the adaptive response by inhibiting repair pro-
cesses but antioxidants such as a-tocopherol can
alleviate this effect [55]. a-Tocopherol (commonly known
as vitamin E) is a fat-soluble vitamin compound naturally
occurring in mammalian cell membranes, and it is a
potent free-radical scavenger believed to play a major
role in the natural defence against lipid peroxidation in
cell membranes [56]. The radioprotective effect of
tocopherol in the small intestine (notoriously known for
its rapid cell turnover and, therefore, for its being among
the main targets for radiation toxicity) has been directly
demonstrated by Franza et al. in mice [57]. Other authors
[58] reported that oral administration of tocopherol prior
to gamma-irradiation in male mice had a radioprotective
effect on spermatogenesis. Considering the famous
‘rodent repairadox’ phenomenon, it is unclear whether
these ﬁndings may apply to cells from other species, and
especially human cells. Laurent et al. [59], however,
showed that the combination of a-tocopherol and the
peripheral vasodilator pentoxifylline in skin ﬁbroblasts
was highly efﬁcient in reducing delayed radiation-
induced damage. It was found that the protective effect
of a-tocopherol may conceal a radioadaptive response
in murine bone marrow cells [55].
Bystander effect
Like all types of electromagnetic radiation, IR travels in a
straight line until absorbed or deﬂected. Thus, it is possi-
ble that a narrow beam of IR may irradiate only an iso-
lated portion of the body, although there is always a
degree scattering as IR traverses living tissue. The latter
allows for ﬁne shaping of external radiotherapy beams
and may be among the causes for survival of individuals
that have received high doses of IR (if we could remem-
ber the infamous case of Anatoly Bugorski, a scientist
from the former Soviet Union who survived after
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receiving an estimated dose of 200 Gy to the head, albeit
in a narrow beam). Nevertheless, it has been well docu-
mented that when a cell population (in vitro or in vivo) is
exposed to IR, the effects of the irradiation may be
observed in a larger proportion of cells than may be
assumed to have been directly irradiated. This phenome-
non (bystander effect) is usually explained by cell–cell
signalling between irradiated cells and closely located
non-irradiated cells. Speciﬁcally, the bystander effect has
been attributed to communication between irradiated
and unirradiated cells by direct contact between neigh-
bouring cells; signalling via speciﬁc substances in the
nutrient medium of irradiated cells that inﬂuenced unir-
radiated cells and immunity-mediated responses
[43,60,61]. Microarray studies revealed that the proﬁle of
gene expression in irradiated cells was different from
that in unirradiated cells which exhibited evidence of
bystander effect, with only part of the genes whose
expression has been modulated in the irradiated cells
being altered in unirradiated cells receiving media from
irradiated cells [62]. Moreover, the bystander effect could
reportedly be elicited in unirradiated cells using cells
that have received irradiation decades ago [63].
Bystander effect is believed to be at least partially
responsible for the risk of occurrence of secondary leu-
kaemia in cancer survivors that have been treated with
radio- or chemotherapy for the primary tumour [64,65].
It is possible that bystander effect may account for at
least some of the errors in biodosimetry by conventional
cytogenetics, as the effects of irradiation such as chro-
mosome instability may be manifested in bystander cells
that have not received irradiation but may, similarly to
irradiated cells, be prone to increased rates of cell death
and/or carcinogenic transformation.
Environmental factors
Individual radiosensitivity may depend (sometimes sig-
niﬁcantly) on environmental factors, such as lifestyle and
diet, physical activity, psychoemotional state, hormonal
status, use of certain drugs, infections, etc. Those are
unspeciﬁc factors that are very common and are prone
to periodic and/or sudden change; therefore, it is difﬁcult
to take these into assumption when assessing the reli-
ability of biodosimetry results. There are also many spe-
ciﬁc environmental agents (e.g. industrial chemicals)
that are quite common and may seriously interfere with
biodosimetric assessments, as they are capable of modu-
lating the genotoxic effects of IR. The effects of these
agents (alone or in combination with other agents) may
not be studied well enough to predict the effects they
may have on biodosimetry results. Residual amounts of
industrial chemicals that are known (to affect individual
radioresistance (e.g. fertilizers, herbicides, etc.) may eas-
ily leak into human food and water (e.g. via contamina-
tion of groundwater [66]) and may modulate the cellular
response to genotoxic insults. The delayed effects may
be difﬁcult to predict, as they occur as a result of a com-
plex interplay of the genetic background, the lifestyle
factors and the additional environmental challenge pro-
vided by the genotoxic agent/s. At present, the data
about the delayed genetic effects of combinations of dif-
ferent genotoxic agents is quite limited, although there
have been studies of the effects of combined genotoxic
challenge on mammalian cells (physical and chemical
agents together, e.g. IR and genotoxic chemicals)
[53,67,68] and of combinations of genotoxic chemicals –
commonly used fertilizers (sodium nitrite, sodium
nitrate) and the herbicide Sencor® (metribuzin) in mice
and human cells. Speciﬁcally, it was found that sodium
nitrite and sodium nitrate administered per os in
amounts that were not associated with an increase in
the overall mutation rate, signiﬁcantly sensibilized irradi-
ated mice to the genotoxic effects of IR (expressed as 2–
4-fold increases in the rates of cytogenetically detectable
chromosomal aberrations) [68]. There have also been
studies of the potential effect of Sencor® on the radio-
sensitivity of irradiated mice [67]. Unlike sodium nitrite
and sodium nitrate, which had no detectable mutagenic
effects in low concentrations, intraperitoneal or oral
administration of Sencor® in unirradiated mice and add-
ing of Sencor® to the nutrient medium of unirradiated
human cultured cells resulted in an increase in the rate
of occurrence of chromosomal translocations. Applica-
tion of Sencor®, however, resulted in reduction of the
levels of chromosomal aberrations in murine germ cells
[67,68]. The effect was more pronounced with chronic
administration of the genotoxic combination Sencor/
irradiation than in acute settings. This effect may be
explained by stimulation of the programmed cell death
pathway in cells that have sustained too much damage.
Generally, the mode of action of Sencor® in plant cells is
based on inhibition of the electron ﬂow between the pri-
mary and secondary electron acceptors of photosystem
II [69]. In mammalian cells, a similar effect may disrupt
the electron transport chain of oxidative phosphoryla-
tion, resulting in increase of the reactive oxygen species
and subsequent oxidative damage (oxidized bases in
DNA, double-strand breaks). This may explain the muta-
genic properties of Sencor® in mammalian cells. IR
causes more than one type of damage in DNA, including
oxidative damage. The latter is a potent inductor of the
DNA repair response pathway, but also of programmed
cell death [70]. Thus, it is possible that the concomitant
administration of both genotoxic agents may result in
rapid induction of apoptosis, leaving very little viable
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cells with detectable translocations. Similar results have
been obtained with Drosophila [53].
Radioprotective properties of melanin
Melanin is a skin pigment that plays a variety of roles,
including protection of the germinative layer of the skin
from the harmful effects of UV irradiation [71]. Melanin is
produced in specialized cells (melanocytes) in the skin
and its appendages (the basal layer of the skin and the
hair follicle), in the eye (choroidal melanocytes and reti-
nal pigment epithelial cells), the inner ear, the brain
meninges and in other tissues and organs, such as the
liver, the heart, the bone and the adipose tissue. Princi-
pally, the amount and type of melanin produced in the
mammalian skin and eye are genetically determined,
but this may be modulated by a variety of factors, includ-
ing age, hormonal status and exposure to UV light. Mela-
nin is an efﬁcient converter of electromagnetic energy. It
participates readily in processes of electron transfer and
is an efﬁcient free-radical scavenger [71–73]. Beverages
such as tea, coffee and cocoa and foodstuffs such as
grapes, bananas and edible fungi contain melanin-like
pigments [74,75]. There have been reports that melanin
could be among the causes for the phenomenon of
increased survival of fungi growing on nuclear test sites
after receiving multiple lethal radiation doses (after soil
irradiation with 6400 Gy) [76]. It has been shown that the
populations of plants with intensive pigmentation
increased in areas contaminated with 90Sr [77]. The phe-
nomenon of hyperpigmentation (on selected sites,
accompanied by fur greying) was also described in mice
undergoing daily gamma-irradiation [78]. Brunst [79]
reported that irradiation of young axolotls with increas-
ing doses of IR stimulated the production of melanin in
the liver, the brain and the eyes, which he viewed as a
potential protective mechanism.
Studies on the antimutagenic properties of melanin
are still sparse in the specialized literature. Previous
reports show that melanin may signiﬁcantly decrease
the rates of occurrence of different types of IR-induced
mutations in germinative cells of model animals (Dro-
sophila, mice) and in cultured human keratinocytes [80–
83]. Melanin has been shown to protect against the
harmful effects of IR not only in acute settings, but also
after chronic exposure [84]. There have been a number
of studies dedicated to the potential uses of melanin as
an agent increasing biological radioresistance. Berdishev
[85] found increased survival and longer life expectancy
of irradiated white mice that have received intraperito-
neal injections of melanin prior to irradiation with 8 Gy, a
dose that normally results in death of mice after 6–
14 days. Nevertheless, as rodents have a unique DNA
repair proﬁle, the results obtained with mice may not be
directly applicable to other species, including humans.
It is possible that increased concentrations of melanin
in the skin and the viscera may alleviate the effects of
exposure to IR. Melanin exerts its protective action at the
initial stage of irradiation, absorbing and converting
high-energy electromagnetic radiation and reducing the
levels of free radical species, thereby preventing DNA
damage [71,86]. Thus, individual characteristics such as
melanin content may affect individualized biodosimetri-
cal measurements.
Conclusions
Radiosensitivity is subject to individual variation, i.e. the
responses of different individuals to the same absorbed
dose of radiation may be quite different. This natural var-
iation is related primarily to differences in the genetic
background due to carriership of variant alleles of genes
coding for products functioning in DNA repair but may
be modulated by other factors as well (radioadaptive
response induced by previous exposure to low-dose
electromagnetic radiation and/or exposure to speciﬁc
chemical agents, bystander effect, etc.). Environmental
factors may also play a role. Lifestyle changes, changes
in hormonal status, acute or chronic stress and infections
may also affect individual radiosensitivity. Popularly used
beverages and foodstuffs may contain substances with
antioxidant properties (e.g. tocopherol, melanin and
others) and/or residual amounts of agents (fertilizers,
herbicides, etc.) that may modulate response to IR. The
contribution of these largely uncontrolled factors may
be responsible for signiﬁcant errors of biodosimetrical
evaluations. Moreover, the cells that are most commonly
collected for the purposes of individualized analysis
(peripheral lymphocytes) appear not to reﬂect correctly
the levels of radiation damage in other tissues and
organs and the organism as a whole. Future studies may
be needed in order to elucidate the relationship
between received dose and individual reaction to radia-
tion damage.
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